Upcoming event

Curriculum: Personalised management of Prostate Cancer patients with history and risk of CVD events

This online curriculum addresses the unmet needs in personalised management of Prostate Cancer patients with history and risk of CVD events and is a mix of live webinars, case discussions, Q&A and discussions by key opinion leaders in prostate cancer. The programme is developed by The Canadian Urological Association, the International Cardio-Oncology Society together with the European Association of Urology.

The curriculum is divided in a series of educational online modules, each one consisting of pre-recorded sessions and a live webinar. Participants are recommended to watch the pre-recorded lectures as a preparation for the live webinar. Attending the live webinar is free (registration required) and participants joining live will receive accreditation points.

Upcoming webinar

Webinar series: Principles of Optimal Multidisciplinary Management in Clinical Practice

Webinar 4: Ongoing Clinical Research in Prostate Cancer: What can we anticipate?
Date: Monday, November14 – 6:00 PM

Moderators:

This session will cover the future of prostate cancer survivorship research:

Topics to cover in this session:

On Demand

Webinar series: Principles of Optimal Multidisciplinary Management in Clinical Practice

Webinar 3: Collaborative Practice in Prostate Cancer: How is this actually done?
Date: Monday, September 12 – 6PM
Moderators:

This session will involve the presentation of challenging cases highlighting issues encountered in actual clinical decision making.

Topics to cover in this session:

Webinar 2: How have the recent clinical trials in Prostate Cancer informed my practice choices?

Webinar 1: What clinical factors influence treatment decisions for localized prostate cancer?


Read a summary of the first two webinars here.

Module 4: Future directions in PCa management

Live webinar

Module 3: Advances in safety in the treatment of PCa

Pre-recorded lectures

Live webinar

Module 2: Debate – How to manage CVD risk in PCa  patients during COVID 19

Live webinar

Module 1: CVD in prostate cancer patients – Increased risks & comorbidities

Pre-recorded lectures

Live webinar

Cardiovascular considerations in PCa patients treated with ADT

This educational activity has been funded by Ferring Pharmaceuticals. The educational programme of this online activity has been a collaboration with Ferring, but independently developed and approved by the Canadian Urological Association, the International Cardio-Oncology Society together with the European Association of Urology.